These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 17879368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C, Austin RM.
    Cancer; 2008 Aug 25; 114(4):242-8. PubMed ID: 18484643
    [Abstract] [Full Text] [Related]

  • 6. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM, Kuebler DL, Wilbur DC.
    Diagn Mol Pathol; 2007 Sep 25; 16(3):125-9. PubMed ID: 17721319
    [Abstract] [Full Text] [Related]

  • 7. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
    Zhao FH, Hu SY, Bian JJ, Liu B, Peck RB, Bao YP, Pan QJ, Frappart L, Sellors J, Qiao YL.
    Cancer Cytopathol; 2011 Dec 25; 119(6):387-94. PubMed ID: 21774094
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of 14 human papillomavirus genotypes in cervical samples in women from a central-southern area of Italy showing different Pap test results.
    Zappacosta B, Romano L, Guerriero M, Graziano M, Vitrani A, De Ninno M, Carbone A.
    New Microbiol; 2009 Oct 25; 32(4):351-8. PubMed ID: 20128441
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reflex human papillomavirus DNA testing on residual liquid-based (TPPT) cervical samples: focus on age-stratified clinical performance.
    Sarode VR, Werner C, Gander R, Foster B, Fulmer A, Saboorian MH, Ashfaq R.
    Cancer; 2003 Jun 25; 99(3):149-55. PubMed ID: 12811855
    [Abstract] [Full Text] [Related]

  • 13. Molecular testing of human papillomavirus in cervical specimens.
    Gazzaz FB.
    Saudi Med J; 2007 Dec 25; 28(12):1810-8. PubMed ID: 18060207
    [Abstract] [Full Text] [Related]

  • 14. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing.
    Johnston EI, Logani S.
    Cancer; 2007 Jun 25; 111(3):160-5. PubMed ID: 17506090
    [Abstract] [Full Text] [Related]

  • 15. Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results.
    Zhao C, Weng B, Li Z, Yang H, Austin RM.
    Am J Clin Pathol; 2013 Jan 25; 139(1):32-8. PubMed ID: 23270896
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus detection: verification with cervical cytology.
    Matthews-Greer J, Rivette D, Reyes R, Vanderloos CF, Turbat-Herrera EA.
    Clin Lab Sci; 2004 Jan 25; 17(1):8-11. PubMed ID: 15011974
    [Abstract] [Full Text] [Related]

  • 17. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
    Wright TC, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, Hatch K, Noller KL, Roach N, Runowicz C, Saslow D.
    Obstet Gynecol; 2004 Feb 25; 103(2):304-9. PubMed ID: 14754700
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.
    Cytopathology; 2009 Aug 25; 20(4):249-55. PubMed ID: 19018810
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M, Zhao C.
    J Low Genit Tract Dis; 2011 Apr 25; 15(2):105-9. PubMed ID: 21317806
    [Abstract] [Full Text] [Related]

  • 20. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M, Berkowitz Z, Yabroff KR, Wideroff L, Kobrin S, Benard V.
    Arch Intern Med; 2010 Jun 14; 170(11):977-85. PubMed ID: 20548011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.